Close
Show

Press Releases

Press Releases is unique and effective promotional tool offered from Worldpharmatoday.com aimed at bringing our client’s business message into limelight and more importantly make it reach their target audience. This feature can be utilized to launch new product, promoting existing Pharma product, publish business agreements, annual reports, financial results, corporate performances, important announcements or any important information that has to be conveyed to the target audience.

Bristol-Myers Squibb and Pfizer Sign Collaboration with Portola Pharmaceuticals to Develop and Commercialize Investigational...


Bristol-Myers Squibb Company (NYSE:BMY) and Pfizer Inc. (NSYE:PFE) today announced that the companies have entered...

Bristol-Myers Squibb Foundation Awards Eight Grants Totaling Nearly $11.5M to Make Lung and Skin...


"The grant from the Bristol-Myers Squibb Foundation will allow us the opportunity to better reach...

U.S. FDA Accepts Filing Of Cardiovascular Outcomes Data For Jardiance® (Empagliflozin)


The U.S. FDA accepted a supplemental New Drug Application for Jardiance based on cardiovascular risk...

U.S. Food And Drug Administration Approves Humulin® R U-500 KwikPen®


The U.S. Food and Drug Administration (FDA) has approved Eli Lilly and Company's (NYSE: LLY)...

Lilly And Roche Diagnostics To Collaborate On Alzheimer’s Disease Adjunct Diagnostic ToolEli Lilly and...


Eli Lilly and Company (NYSE: LLY) today announced an arrangement to partner with Roche Diagnostics...

Bristol-Myers Squibb’s Opdivo (nivolumab) + Yervoy (ipilimumab) Regimen Receives Expanded FDA Approval in Unresectable...


Announcement in the U.S. that Food and Drug Administration (FDA) has approved Opdivo (nivolumab) in...

Nutrition and health bars expand market share by tying into wellness, athleticism


Nutrition and health bars are stealing market share from the category leading snack and cereal...

FDA approves two new drug treatments for diabetes mellitus


The U.S. Food and Drug Administration today approved Tresiba (insulin degludec injection) and Ryzodeg 70/30...

AstraZeneca and Tianjin Medical University sign cardiovascular research collaboration in China


AstraZeneca today announced the signing of a research collaboration in the area of cardiovascular diseases...

AstraZeneca and Orca Pharmaceuticals announce research collaboration to identify best-in-class ROR? inhibitors to treat...


AstraZeneca and Orca Pharmaceuticals, a UK based biopharmaceutical company, today announced a three year collaboration...